REGENERON PHARMACEUTICALS, INC. (REGN)

SEC filing

REGENERON PHARMACEUTICALS, INC.

REGN · CIK 872589

4 · Oct 15, 2026 · Co-Chief Scientific Officer MURPHY ANDREW J sold 4,147 shares at $772.70/share ($3.2M); exercised options for 34K shares; reported 12.85K shares

Co-Chief Scientific Officer MURPHY ANDREW J sold 4,147 shares at $772.70/share ($3.2M); exercised options for 34K shares; reported 12.85K shares

Filed: Oct 15, 2026
Period: Oct 13, 2026
Accession: 0001796226-26-000002
Filer: REGENERON PHARMACEUTICALS, INC.

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/edgardoc.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTedgardoc.xml
Open SEC.gov